Detalhe da pesquisa
1.
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Cancer
; 130(9): 1663-1672, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127583
2.
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Br J Haematol
; 204(5): 1944-1952, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448009
3.
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts.
Am J Hematol
; 99(2): 245-253, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100199
4.
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
Am J Hematol
; 99(5): 890-899, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444268
5.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400519
6.
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Cancer
; 129(8): 1205-1216, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738229
7.
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Br J Haematol
; 201(4): 738-746, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733986
8.
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
Br J Haematol
; 202(4): 866-873, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376789
9.
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
Br J Haematol
; 200(1): 35-44, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068929
10.
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
BMC Cancer
; 23(1): 1258, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124057
11.
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
Am J Hematol
; 98(10): 1571-1578, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461327
12.
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Blood
; 135(6): 449-452, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826244
13.
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Haematologica
; 107(4): 844-856, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435482
14.
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Haematologica
; 107(4): 899-908, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951890
15.
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Curr Treat Options Oncol
; 23(11): 1614-1625, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227407
16.
Chimeric antigen receptor T-cell therapy toxicities.
Br J Clin Pharmacol
; 87(6): 2414-2424, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463929
17.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
18.
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(5): 1013-1020, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045652
19.
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Biol Blood Marrow Transplant
; 26(10): 1759-1769, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623078
20.
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(1): 197-203, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518645